miRNA in the Progression of Diabetic Kidney Disease: New Insight

Area of Science:

• Nephrology
• Molecular Biology
• Genetics

Background:

• Diabetic kidney disease (DKD) is a severe complication of diabetes, increasing end-stage renal disease globally.
• Despite improved management, DKD prevalence and its socioeconomic impact are rising.
• Non-coding RNAs, especially microRNAs (miRNAs), are increasingly recognized for their roles in DKD pathogenesis.

Purpose of the Study:

• To review the cell-specific roles of microRNAs in DKD development and progression.
• To highlight the potential of miRNAs as diagnostic biomarkers and therapeutic targets for DKD.

Main Methods:

• Review of recent scientific literature on miRNA involvement in DKD.
• Analysis of cell-specific miRNA expression patterns and their functional consequences in renal cells.
• Examination of circulating and urinary miRNAs as potential biomarkers.

Main Results:

• miRNA dysregulation occurs in various renal cell types (podocytes, mesangial cells, tubular cells, etc.), contributing to DKD-related injuries.
• Specific miRNAs (e.g., miR-21, miR-192) promote fibrosis via TGF-β/Smad signaling.
• Other miRNAs (e.g., miR-29, miR-30) exhibit protective effects on renal cells and matrix deposition.

Conclusions:

• Cell-specific miRNA networks are critical in DKD pathogenesis.
• miRNAs hold promise as non-invasive biomarkers for DKD diagnosis and monitoring.
• Targeting specific miRNAs represents a potential strategy for precision medicine in DKD management.